Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "Global Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex-vivo, In-vivo), Application, Mode, End-use, Region, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The global genome editing market size is expected to reach USD 25.00 billion by 2030, exhibiting a CAGR of 16.94% from 2024 to 2030. The increasing advancements in genome editing technology, the growing funding & investments in the genomics industry, the increasing prevalence of genetic disorders, and the need for improved treatments and therapies are major factors driving revenue growth. 
The evolution of genome editing technologies is another contributing factor to drive revenue growth in the market. Most effective and accurate gene editing is now possible through the enhancement of new and advanced genome editing methods including CRISPR-Cas13,prime editing, and base editing, amongst others. This creates genome editing methods used more often in academic and medical contexts. For instance, in January 2020, ERS Genomics and New England Biolab collaborated to develop and commercialize CRISPR gene modification tools & reagents.
The increasing application of gene-modification tools in therapeutic research has resulted in the rising number of advanced therapeutics entering clinical trials. Furthermore, the use of artificial intelligence to advance the implementation of novel gene modification systems exhibits great potential for the technology developer. This is anticipated to greatly favor revenue generation in the foreseeable future. Research communities are exploring the potential of gene-modification instruments such as CRISPR as a potential fast screening solution for various chronic diseases. Such research programs are likely to benefit the market for genome editing in the coming years.
Genome Editing Market Report Highlights
- By technology, The CRISPR/Cas9 segment held the largest market share of 43.52% of the global revenue in 2023.
- The ex-vivo segment dominated the market with a share of 51.24% in 2023. This dominance can be attributed to the ease of control in DNA modification provided along with the precise regulation of strength and duration of nuclease expression to minimize off-target editing and maximize efficiency.
- The genetic engineering segment held the largest market share in 2023. The segment is further categorized into cell line engineering, animal genetic engineering, plant genetic engineering, and others.
- The contract segment dominated the market in 2023 due to the high extent of outsourcing activities in the genomics space driven by the lower costs and greater flexibility in operations offered by such activities as compared to in-house development.
- The biotechnology and pharmaceutical companies segment accounted for the largest market share of 50.95% in 2023.
- North America dominated the market and accounted for a 47.81% share in 2023 owing to the growing investments in the R&D of gene editing technologies.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $7.96 Billion |
| Forecasted Market Value (USD) by 2030 | $25 Billion |
| Compound Annual Growth Rate | 16.9% |
| Regions Covered | Global |
Competitive Landscape
- Merck KGaA
- Cibus Inc
- Recombinetics
- Sangamo Therapeutics
- Editas Medicine
- Precision BioSciences
- CRISPR Therapeutics
- Intellia Therapeutics, Inc
- Caribou Biosciences, Inc.
- Cellectis S.A
- AstraZeneca
- Takara Bio Inc.
- Horizon Discovery Ltd. (Revvity, Inc.)
- Danaher Corporation
- Transposagen Biopharmaceuticals, Inc.
- Genscript Biotech Corp
- New England Biolabs
- OriGene Technologies, Inc.
- bluebird bio, Inc
- Lonza
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Genome Editing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Success in Pre-clinical Models Drives Demand for Genome Editing Therapeutics
3.2.1.2. Rising Competition Amongst Market Participants for Business Development
3.2.1.3. Easy Editing Solutions for the Development of Therapeutics for a Broad Range of Diseases
3.2.1.4. Increasing Demand for Synthetic Genes and Genetically Modified Organisms
3.2.1.5. Technological Advancements in Gene Editing Technologies
3.2.1.6. Rising Adoption in Agricultural Biotechnology
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges Concerning Clinical Translation
3.2.2.2. Regulatory, Scientific, and Ethical Challenges Regarding the Use of Genetically Modified Products
3.2.2.3. Off-target Effects of CRISPR Technology
3.3. Genome Editing Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Genome Editing Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Genome Editing Market Technology Movement Analysis
4.3. Global Genome Editing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
4.4. (CRISPR)/Cas9
4.5. TALENs/MegaTALs
4.6. ZFN
4.7. Meganuclease
Chapter 5. Genome Editing Market: Delivery Method Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Genome Editing Market Delivery Method Movement Analysis
5.3. Global Genome Editing Market Size & Trend Analysis, by Delivery Method, 2018 to 2030 (USD Million)
5.4. Ex-vivo
5.5. In-Vivo
Chapter 6. Genome Editing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Genome Editing Market Application Movement Analysis
6.3. Global Genome Editing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Genetic Engineering
6.4.1. Genetic Engineering Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Cell Line Engineering
6.4.3. Animal Genetic Engineering
6.4.4. Plant Genetic Engineering
6.5. Clinical Applications
6.5.1. Clinical Applications Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. Diagnostics
6.5.3. Therapy Development
Chapter 7. Genome Editing Market: Mode Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Genome Editing Market Mode Movement Analysis
7.3. Global Genome Editing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
7.4. Contract
7.5. In-house
Chapter 8. Genome Editing Market: End-use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Genome Editing Market End-use Movement Analysis
8.3. Global Genome Editing Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
8.4. Biotechnology and Pharmaceutical Companies
8.5. Academic and Government Research Institutes
8.6. Contract Research Organizations
Chapter 9. Genome Editing Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
For more information about this report visit https://www.researchandmarkets.com/r/xpxh45
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
